Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago
More from this buyer
Full buyer profile173 open tenders right now
- Health and social services - Workplace health promotion nutrition services 3 days left
- Medical software package - Software for hospital invoice auditing 9 days left
- E-bike and EV charging stations 9 days left
Recent awards
- Medicines - Conclusion of a non-exclusive rebate agreement under § 130a paragraph 8 SGB V for the active ingredient Tacrolimus, ATC L04AD02, for 01.09.2024 - 31.08.2025 (plus extension option 1x12 months)
- Medicines - Non-exclusive rebate agreement under § 130a paragraph 8 SGB V for the active ingredient Ranibizumab, ATC S01LA04 for the period 01.09.2024 - 31.08.2026
- Medicines - Conclusion of a non-exclusive rebate agreement under Section 130a(8) SGB V for the active substance Triptorelin, ATC L02AE04, for the period 01.09.2024 - 31.08.2026
Change history
Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.
-
Read before bidding
- Scope and criteria: The description was expanded. Re-read it before you bid.
- Estimated value: Set to €1
Follow this tender and we email you the moment it changes. Create account
Similar tenders
2
days left
€2,750,000
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €10,066,608
- Buyer track record on Aperlena
- 346 notices tracked · 131 awarded
- €69,640,016 in awarded contracts
Never miss a tender like this
76 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.
Set up my alert